The Synagis story

Rationing Synagis

The Synagis story

NIH holds up Synagis palivizumab as a model for government-industry collaboration to translate basic scientific advances into high-impact therapies to address urgent medical needs. Like several other breakthrough biotech products, the basic science can be traced back to government labs: publicly funded scientists conceived of the approach and proved the

Read the full 539 word article

How to gain access

Continue reading with a
two-week free trial.